4.7 Review

Vitamin K2 Needs an RDI Separate from Vitamin K1

Journal

NUTRIENTS
Volume 12, Issue 6, Pages -

Publisher

MDPI
DOI: 10.3390/nu12061852

Keywords

vitamin K; vitamin K1; vitamin K2; RDI; menaquinone; vitamin K-dependent proteins

Funding

  1. European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [722609, 675111]
  2. Germany Research Foundation (DFG) [SFB TRR219, TP C05]

Ask authors/readers for more resources

Vitamin K and its essential role in coagulation (vitamin K [Koagulation]) have been well established and accepted the world over. Many countries have a Recommended Daily Intake (RDI) for vitamin K based on early research, and its necessary role in the activation of vitamin K-dependent coagulation proteins is known. In the past few decades, the role of vitamin K-dependent proteins in processes beyond coagulation has been discovered. Various isoforms of vitamin K have been identified, and vitamin K2 specifically has been highlighted for its long half-life and extrahepatic activity, whereas the dietary form vitamin K1 has a shorter half-life. In this review, we highlight the specific activity of vitamin K2 based upon proposed frameworks necessary for a bioactive substance to be recommended for an RDI. Vitamin K2 meets all these criteria and should be considered for a specific dietary recommendation intake.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available